Modern concepts on the molecular mechanisms of sulfonylurea effect on KITP channels
https://doi.org/10.14341/probl11749
Abstract
The article is devoted to the review of the modern concepts on the molecular mechanisms of sulfonylurea effect on KITP channels.
About the Authors
F. М. AshcroftOxford University
United Kingdom
F. Reimann
Oxford University
United Kingdom
References
1. Ashcroft FM, Ashcroft SJH. The sulphonylurea receptor. Biochim Biophys Acta. 1992; 1175:45-59.
2. Ashcroft FM, Gribble FM. ATP-sensitive K+ channels and insulin secretion: their role in health and disease. Diabetologia. 1999; 42:903-919.
3. Ashcroft FM, Rosman P. Electrophysiology of the pancreatic b-cell. Prog Biophys Molec Biol. 1989; 54:87-143.
4. Cook DL, Hales CN. Intracellular ATP directly blocks K+ channels in pancreatic b-cells. Nature. 1984; 311:271-273.
5. Kakei M, Kelly RP, Ashcroft SJH, Ashcroft FM. The ATP- sensitivity of K+ channels in rat pancreatic b-cells is modulated by ADP. FEBS Lett. 1986; 208:63-66.
6. Thomas PM, Cote GJ, Wohllk N, et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science. 1995; 268:426-429.
7. Babenko AP, Aguilar-Bryan L, Bryan J. A view of sur/ KIR6.X, KATP channels. Annu Rev Physiol. 1998; 60:667-687.
8. Randle PJ. Glucokinase and candidate gene for type 2 (non- insulin-dependent) diabetes mellitus. Diabetologia. 1993; 36:269-275.
9. Trube G, Rorsman P, Ohno-Shosaku T. Opposite effects of tolbutamide and diazoxide on ATP-dependcnt K+ channel in pancreatic b-cells. PflRgers Arch. 1986; 407:493-499.
10. Aguilar-Bryan L, Nichols CG, Wechsler SW, et al. Cloning of the b-cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science. 1995; 268:423-426.
11. Edwards G, Weston AH. The pharmacology of ATP-sensitive potassium channels. Annu Rev Pharmacol Toxicol. 1993; 33:597-637.
12. Inagaki N, Gonoi T, Clement IV JP, et al. Reconstitution of IKAPT: an inward rectifier subunit plus the sulfonylurea receptor. Science. 1995; 270:1166-1170.
13. Sakura H, AmmKIK C, Smith PA, Gribble FM, Ashcroft FM. Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel expressed in pancreatic b-cells, brain, heart abd skeletal muscle. FEBS Lett. 1995; 377:338-344.
14. Clement IV JP, Kunjilwar K, Gonzalez G, et al. Association and stoichiometry of KATP channel subunits. Neuron. 1997; 18:827-838.
15. Tucker SJ, Gribble FM, Zhao C, Trapp S, Ashcroft FM. Truncation of Kir6.2 produces ATP-sensitive К-channels in theabsence of the sulphonylurea receptor. Nature. 1997; 387:179-181.
16. Gribble FM, Tucker SJ, Ashcroft FM. The interaction of nucleotides with the tolbutamide block of KATP currents: a reinterpretation. J Physiol. 1997; 504:35-45.
17. Gribble FM, Tucker SJ, Seino S, Ashcroft FM. Tissue specificity of sulfonylureas: studies on cloned cardiac and b-cell KATP channels. Diabetes. 1998; 47:1412-1418.
18. Gribble FM, Ashcroft FM. Differential sensitivity of b-cell and extrapancreatic KATP channels to gliclazide. Diabetologia. 1999;42:845-848. '
19. ZRnkier BJ, Lins S, Ohno-Shosaku T, Trube G, Panten U. Cytosolic ADP enhances the sensitivity of tolbutamide of ATP-dependent K+ channels from pancreatic b-cells. FEBS Lett. 1988; 239:241-244.
20. Sator G, Melander A, ScherstOn B, WMhein-Boll E. Influence of food and age on the single-dose kinetics and effects of tolbutamide and chlorpropamide. Eur J Clin Pharmacol. 1980; 17:285-293.
21. Sator G, Melander A, ScherstOn B, WMhein-Boll E. Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide. Diabetologia. 1980; 18:17-22.
22. Nichols CG, Lederer WJ. Adenosine triphosphate-sensitive potassium channels in the cardio-vascular system. Am J Physiol. 1991; 261: H1675-H1686.
23. Quayle JM, Nelson MT, Standen NB. ATP-sensitive and inwardly-rectifying potassium channels in smooth muscle. Physiol Rev. 1997; 77:1165-1232.
24. Davis NW, Standen NB, Stanfield PR. ATP-dependent potassium channels of muscle cells: their properties, regulation, and possible functions. J Bioenerg Biomembr. 1991; 23:509-535.
25. Schmid-Antomarchi H, Amoroso S, Fosset M, Lazdunski M. K+ channel openers activate brain sulfonylurea-sensitive K+ channels and block neurosecretion. Proc Natl Acad Sci USA. 1990; 87:3489-3492.
26. Heurteax C, Bertaina V, Widmann C, Lazdunski M. K+ channel openers prevent global ischemia-induced expression of c- fos, c-jun, heat shock protein and amyloid b-protein precursor genes and neuronal death in rat hippocampus. Proc Natl Acad Sci USA. 1993; 90:9431-9435.
27. Venkatesh N, Lamp ST, Weiss JN. Sulfonylureas, ATP-sensitive K+ channels and cellular К ‘ loss during hypoxia, ischemia and metabolic inhibition in mammalian ventricle. Circ Res. 1991; 69:623-637.
28. UKPDS: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type-2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
29. Leibowitz G, Cerasi E. Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing? Diabetologia. 1996;39:503-514.
Review
For citations:
Ashcroft F.М., Reimann F. Modern concepts on the molecular mechanisms of sulfonylurea effect on KITP channels. Problems of Endocrinology. 2001;47(6):42-47. (In Russ.) https://doi.org/10.14341/probl11749
Views:
1964
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
